13F

Stock

Lisata Therapeutics, Inc.

LSTA · held by 26 managers

Reported value

$1.36M

Holders

26

+0 new · −1 exited

Holders’ est. mark

−$7.97K

Price effect on 2 books still in the name

Largest holder

$503.9K

Vanguard

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Vanguard270.9K$503.9K—Held
Renaissance Technologies123.7K$230.1K—Held
BML Capital Management, LLC73.3K$136.4K—Held
GEODE CAPITAL MANAGEMENT, LLC64.4K$119.9K—Held
BlackRock, Inc.54.9K$102K—Held
Ground Swell Capital, LLC39K$72.5K—Held
Cerity Partners LLC12.2K$49.1K—Held
State Street14.3K$26.7K—Held
DIMENSIONAL FUND ADVISORS LP14.3K$26.5K—Held
BANK OF AMERICA CORP /DE/10.4K$19.4K−$7.92KCut−$7.92K
NORTHERN TRUST CORP10.3K$19.1K—Held
HighTower Advisors, LLC10K$18.7K—Held
ROYAL BANK OF CANADA5.91K$11K—Held
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC5K$9.3K—Held
Tower Research Capital LLC (TRC)2.55K$4.75K—Held
Founders Capital Management1.67K$3.1K—Held
Connective Capital Management, LLC1.02K$1.89K—Held
UBS Group AG871$1.62K—Held
NewEdge Advisors, LLC107$199—Held
OSAIC HOLDINGS, INC.100$186—Held
MORGAN STANLEY75$140−$57Cut−$405
Cheviot Value Management, LLC3$14—Held
SBI Securities Co., Ltd.7$13—Held
CITIGROUP INC1$2—Held
Fortitude Family Office, LLC1$2—Held
Fidelity0$0—Held

Who left

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.